1,298
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains

, , , , , , , , , , , , , ORCID Icon, & show all
Pages 1866-1874 | Received 25 Sep 2019, Accepted 21 Dec 2019, Published online: 02 Mar 2020

References

  • WHO. tOPV with bOPV – briefing note February; 2015.
  • Liu Y, Wang J, Liu S, Du J, Wang L, Gu W, Xu Y, Zuo S, Xu E, An Z, et al. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010–2014. Vaccine. 2017;35:1281–86. doi:10.1016/j.vaccine.2017.01.034.
  • Nicoletta PRHT, Tallis G, Jafari HS. World Health Organization guidelines for containment of poliovirus following type-specific polio eradication — worldwide. MMWR Morb Mortal Wkly Rep 2015; 2015.
  • WHO. Polio vaccines: WHO position paper; 2016:145–68. doi:10.1293/tox.24.223e.
  • Hanson CM, George AM, Sawadogo A, Schreiber B. Is freezing in the vaccine cold chain an ongoing issue? A literature review. Vaccine. 2017;35:2127–33. doi:10.1016/j.vaccine.2016.09.070.
  • Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007;25:3980–86. doi:10.1016/j.vaccine.2007.02.052.
  • Poy A, van den Ent M, Sosler S, AR H, Brown S, Sodha S, Ehlman DC, Wallace AS, Mihigo R. Monitoring results in routine immunization: development of routine immunization dashboard in selected African Countries in the context of the polio eradication endgame strategic plan. J Infect Dis. 2017;216:S226–S36. doi:10.1093/infdis/jiw635.
  • Das MK, Arora NK, Mathew T, Vyas B, Sindhu M, Yadav A. Temperature integrity and exposure to freezing temperature during vaccine transfer under the universal immunization program in Three States of India. Indian J Public Health. 2019;63:139–42. doi:10.4103/ijph.IJPH_123_18.
  • Yakum MN, Ateudjieu J, Pelagie FR, Walter EA, Watcho P. Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon. BMC Res Notes. 2015;8:277. doi:10.1186/s13104-015-1257-y.
  • Fortpied J, Wauters F, Rochart C, Hermand P, Hoet B, Moniotte N, Vojtek I. Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures. Hum Vaccin Immunother. 2018;14:1243–50. doi:10.1080/21645515.2017.1421878.
  • Chen D, Tyagi A, Carpenter J, Perkins S, Sylvester D, Guy M, Kristensen DD, Jones Braun L. Characterization of the freeze sensitivity of a hepatitis B vaccine. Hum Vaccin. 2009;5:26–32. doi:10.4161/hv.5.1.6494.
  • White JA, Estrada M, Weldon WC, Chumakov K, Kouiavskaia D, Fournier-Caruana J, Stevens E, Gary HE, Maes EF, Oberste MS, et al. Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures. Biol J Int Assoc Biol Stand. 2018;53:30–38. doi:10.1016/j.biologicals.2018.03.002.
  • WHO. Module 2: The vaccine cold chain; 2015.
  • Liao G, Li R, Li C, Sun M, Li Y, Chu J, Jiang S, Li Q. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. J Infect Dis. 2012;205:237–43. doi:10.1093/infdis/jir723.
  • Lu Z. [Determination of polio-neutralizing antibody by the micro-tissue culture technic]. Zhonghua Liu Xing Bing Xue Za Zhi. 1985;6:356–58.
  • Adeniji AJ, Onoja AB, Adewumi MO. Polio virus neutralizing antibody dynamics among children in a north-central and South-Western Nigeria state. J Immunoassay Immunochem. 2015;36:45–53. doi:10.1080/15321819.2014.893889.
  • Crawt L, Atkinson E, Tedcastle A, Pegg E, Minor P, Cooper G, Rigsby P, Martin J. Report on the WHO collaborative study to establish the 1st International Standard for Sabin inactivated polio vaccine (sIPV). Expert Committee On Biological Standardization. Geneva, Switzerland; 2018.
  • Crawt L, Atkinson E, Tedcastle A, Pegg E, Minor P, Cooper G, Lei S, Ling P, Li C, Zheng J, et al. Differences in antigenic structure of inactivated poliovaccines made from Sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays. J Infect Dis. 2019. doi:10.1093/infdis/jiz076.